Insulin in Dosage Market Size Value Per Capita in Belgium

The insulin dosage market size value per capita in Belgium demonstrates a generally increasing trend from 2012 to 2022, with notable fluctuations. From 2012 to 2021, the value per capita rose from 15.17 to 23.12 Percent US Dollars Per Capita, representing a strong upward trend, especially noticeable in recent years. However, 2022 saw a dip to 21.53 Percent US Dollars Per Capita. The year-on-year growth showed volatility, with significant rises like 2020 to 2021's 11.12% increase, followed by a 6.87% decline in 2022. The Compound Annual Growth Rate (CAGR) over the last five years stands at an impressive 5.71%.

Future trends to watch for include:

- Potential market stabilization or continued volatility post-2022 dip.- Influences of healthcare policies and advancements in diabetes management on insulin demand.- Emergence of new insulin delivery technologies and their impact on per capita value.